NeuroSense Therapeutics (NRSN) Prepaid Assets (2023 - 2025)
NeuroSense Therapeutics' Prepaid Assets came in at $80,000 for Q4 2025, down 8.0% from $87,000 a year earlier.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Prepaid Assets (2023 - 2025) Analysis & Trends
- Going back by year, Prepaid Assets was $87,000 in FY2024 (+24.3%) and $70,000 in FY2023.
- The Q4 2025 figure represents the lowest quarterly Prepaid Assets since Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.56 Bn | 1,136.14 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.76 Bn | 554.29 Bn | 17.26 Bn |
| 3 | AbbVie | 503.27 Bn | 476.38 Bn | 12.70 Bn |
| 4 | Merck | 377.51 Bn | 331.89 Bn | 12.21 Bn |
| 5 | Novartis Ag | 304.07 Bn | 268.06 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.22 Bn | 12.86 Bn |
| 7 | Amgen | 242.06 Bn | 197.46 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.26 Bn | 168.46 Bn | 6.22 Bn |
| 9 | Pfizer | 172.62 Bn | 119.27 Bn | 10.94 Bn |
| 10 | NeuroSense Therapeutics | 2.96 Mn | -1.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 80,000.00 |
| Dec 31, 2024 | 87,000.00 |
| Dec 31, 2023 | 70,000.00 |
API Access
NeuroSense Therapeutics Prepaid Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=prepaid-assets&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "prepaid-assets", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=prepaid-assets&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();